11 results about "Celery seed extract" patented technology

The invention belongs to the technical field of health-care food, and particularly relates to a sacha inchi oil-based gel candy with functions of reducing hypertension, hyperglycemia and hyperlipidemia and a preparation method thereof, and the sacha inchi oil-based gel candy comprises the following components: 1) a main component: 30-70% of sacha inchi oil; 2) a blood fat reducing synergistic component which is one or a combination of more of 0.5%-5% of phytosterol, 0.1%-2% of a red yeast rice extract and 0.01%-0.5% of sugarcane octacosanol; 3) a hypoglycemic synergistic component, which comprises one or a combination of more of 5%-20% of inulin / fructo-oligosaccharide, 0.5%-5% of a bitter gourd extract, 0.5%-5% of a mulberry leaf extract and 10-200 [mu] g / grain of chromium; 4) an antihypertensive synergistic component, wherein the antihypertensive synergistic component is one or a combination of more of 500-5000FU / grain of nattokinase, 0.5-5% of a celery seed extract and 1-8% of a hawthorn extract; through scientific compounding, the sacha inchi oil and various synergistic components exert a combined effect, and meanwhile, auxiliary regulation is carried out on blood sugar, blood fat and blood pressure; the main components are derived from natural plant extracts or functional grease, so that the health-care product is high in safety and suitable for daily health care.

This invention provides a composition suitable for lowering uric acid, comprising the following raw materials in weight percentages: 20-45% freeze-dried black goji berry powder, 20-45% chicory powder, 10-20% sour cherry powder, 5-10% celery seed extract, 2-8% turmeric extract, 1-5% vitamin E, and 0.2-1% vitamin B. This invention also provides a method for preparing the above-mentioned composition suitable for lowering uric acid and its applications. The composition of this invention, suitable for lowering uric acid, exhibits synergistic effects from its raw materials, constructing a four-dimensional regulatory mechanism of "inhibiting production + promoting excretion + anti-inflammatory and analgesic + metabolic regulation," resulting in a significant uric acid-lowering effect through multi-target synergistic action. The preparation method of this invention combines "lipid-soluble microencapsulation" and "water-soluble inclusion," improving bioavailability, extending shelf life, and enhancing palatability. All raw materials in this invention are either medicinal and edible or food-grade, with no toxic side effects from long-term consumption and high safety. This invention belongs to the technical field of health foods and functional foods.

The application belongs to the technical field of functional beverages, and discloses a compound beverage rich in selenium and capable of reducing uric acid and a preparation method thereof. The compound beverage contains, per 100 mL, goose myelin, resistant dextrin, inulin, chitooligosaccharide, fish collagen peptide, potassium citrate, vitamin C, turmeric extract, celery seed extract, green tea extract, gardenia extract, black pepper embedding powder, poria extract, coix seed extract, corn silk extract, yam extract, chicory extract, sour cherry extract, phyllanthus extract, microcrystalline cellulose, erythritol, lemon powder, citric acid, natural vanillin, silicon dioxide, stevioside, maltodextrin, and the balance of selenium-rich water. In the preparation, vitamin C and water-soluble ingredients are first dissolved in selenium-rich water, then fat-soluble ingredients are added for dispersion treatment, followed by the addition of the remaining extracts for mixing and dissolution, and the balance of selenium-rich water is added. The product is obtained through filtration, filling, and high-temperature sterilization. The composition of the scheme is clear, the preparation steps are clear, and the scheme is suitable for the preparation of compound beverages.

The invention discloses a compound probiotic composition capable of efficiently degrading uric acid and improving metabolic disorder related diseases and application of the compound probiotic composition, and belongs to the technical field of functional microorganisms. The compound probiotic composition disclosed by the invention comprises a bifidobacterium animalis B401 strain with the preservation number of CGMCC (China General Microbiological Culture Collection Center) No.35205, a lactobacillus acidophilus D801 strain with the preservation number of CGMCC No.35204, a grape seed extract, a celery seed extract, a cactus extract, a corn stigma extract and the like. The compound probiotic composition disclosed by the invention has the functions of preventing and treating metabolic disorder related diseases such as hyperuricemia and the like; the probiotic composition can significantly reduce the content of uric acid after intake of high-purine food, maintain balance of uric acid in the body and relieve body injury caused by high uric acid; the intestinal health is maintained; the probiotic composition is safe, effective and free of toxic and side effects, can provide a new strategy for prevention and treatment of related diseases such as metabolic disorders, and has important clinical significance and wide application prospects.

The invention relates to the technical field of traditional Chinese medicines, and provides a traditional Chinese medicine composition capable of reducing blood fat and eliminating carotid plaques. Comprising the following components in parts by weight: 15-20 parts of radix puerariae, 3-6 parts of natto powder, 8-10 parts of red yeast rice, 2-4 parts of allium macrostemon, 2-4 parts of earthworm protein, 5-8 parts of peach kernels, 2-6 parts of perilla seeds, 1-2 parts of soybean peptide powder, 12-15 parts of a grape seed extract, 8-10 parts of a celery seed extract, 1-2 parts of selenium-enriched triticale peptide, 2-3 parts of saffron and 2-4 parts of turmeric. According to the technical scheme, the problem that a traditional Chinese medicine composition in the related technology is poor in blood fat reducing effect is solved.

This invention belongs to the food field, specifically health food, and discloses a Euglena composition for improving gout and its preparation method. The composition is prepared from the following raw materials in parts by weight: 3-8 parts of Coix seed, 3-8 parts of Poria cocos, 0.1-6 parts of Gardenia jasminoides, 0.1-6 parts of Imperata cylindrica root, 2-5 parts of corn silk, 2-5 parts of Pueraria lobata root, 0.1-10 parts of Euglena galanga powder, 0.1-5 parts of Lactobacillus plantarum powder, 0.1-4 parts of mangiferin, 0.1-6 parts of celery seed extract, and 0.1-5 parts of sour cherry extract. The preparation process is efficient and controllable, and the application is safe and effective.

The invention discloses a uric acid reducing composition based on multi-target synergistic effect and application thereof, and is characterized in that the uric acid reducing composition comprises the following components: tuna peptide extract, gardenia extract, poria cocos extract, chicory extract, celery seed extract, cinnamon extract, kudzu vine root extract, chitosan oligosaccharide, citric acid and vitamin C, the total mass of the tuna peptide extract and the poria cocos extract accounts for 60% or above of the total mass of the composition, and the composition has the advantages that the blood uric acid level can be quickly regulated and controlled, the kidney function is protected, and the inflammatory response is relieved.

The invention discloses combined nutrition powder for preventing hypertension and a preparation technology of the combined nutrition powder, and relates to the technical field of health-care food. The active components comprise 12-18 parts of a celery seed supercritical extract with a specific content, 8-12 parts of marine-derived oligopeptide with a specific molecular weight and inhibitory activity, and 10-16 parts of a jerusalem artichoke synanthrin-organic chromium compound with a specific chromium form; the auxiliary components comprise 15-22 parts of a high-potassium-magnesium plant matrix with a specific ratio and particle size, and 25-35 parts of a carrier and a stabilizer with a specific ratio; and the nutrition powder has clear indexes on the angle of repose, the dissolution time and the in-vitro antihypertensive activity. The active ingredients are precisely compounded, the celery seed extract, the marine-derived oligopeptide and the jerusalem artichoke inulin-organic chromium compound regulate blood pressure at multiple targets, the in-vitro angiotensin converting enzyme inhibition rate is larger than or equal to 78%, the effect is remarkable when the composition is taken by specific people for 8 weeks according to the dosage, activity retention and quality stability are both considered through the steps of pretreatment, multi-stage mixing and the like, and the composition is suitable for being used for a long time. And nitrogen-filled packaging guarantees the storage period quality.

The application discloses a sports nutrition food for assisting intervention of hyperuricemia. 40g of the sports nutrition food contains soybean protein isolate, whey protein, resistant dextrin, inulin, Job's tears powder, poria cocos powder, adzuki bean powder, goose myo-inositol, celery seed extract, gardenia extract, chicory extract, sour cherry powder, vitamin C, caffeine and mineral and probiotic premix. The premix contains 3.0mg of vitamin B2, 800ug of folic acid, multiple minerals and probiotics. Vitamin B2 inhibits urate crystallization through a dual mechanism, folic acid and vitamin C synergistically reduce blood uric acid, and celery seeds, chicory and gardenia inhibit xanthine oxidase. 12 weeks of diet and exercise can reduce blood uric acid by 50-58% and reduce gout attack frequency by 85-90%. All ingredients meet the national standard of sports nutrition food and are safe and compliant.

The present invention relates to a composition for preventing, improving, or treating diseases associated with muscle weakness, comprising a celery seed extract. The celery seed extract according to the present invention is a natural product and can increase muscle mass and strength with few or no side effects. Therefore, it is expected that the celery seed extract according to the present invention can be useful for preventing, improving, or treating diseases associated with muscle weakness, metabolic diseases, liver diseases, etc., since it can increase muscle mass and strength with few or no side effects by using a natural product and can not only prevent muscle weakness, but also inhibit increases in body weight and body fat, and reduce blood lipid concentrations and liver toxicity indicators (GOT and GPT).

The invention discloses a functional solid beverage capable of protecting kidney and liver, rapidly reducing uric acid, alkalizing urine and preventing and treating gout and a preparation method of the functional solid beverage, and belongs to the technical field of health-care food. The solid beverage is prepared from the following raw materials in parts by weight: potassium citrate, a celery seed extract, a chicory extract, a corn stigma extract, lily freeze-dried powder, a green tea extract, ascorbic acid, green papaya powder, erythritol, coconut powder and silicon dioxide. The preparation method comprises the following steps: pretreating the raw materials, grading and mixing, sieving and homogenizing, and sterilizing and packaging. The core of the invention lies in that the kidney and liver protection is taken as the guide, the potassium citrate and the celery seed extract have a synergistic effect, a dual uric acid reduction mechanism of quickly alkalizing urine and inhibiting uric acid generation is realized, and meanwhile, various natural extracts are supplemented to achieve the comprehensive conditioning effects of resisting inflammation, resisting oxidation and inducing diuresis. The product is taken twice a day, one bag (15g) each time, has the advantages of quick effect, good taste and high cost performance, and is suitable for daily diet auxiliary conditioning of people with hyperuricemia and gout.